blue triangle graphic

Terms of Use

blue triangle graphic

Terms of Use


These terms and conditions of use describe the terms and conditions applicable to your use of Alkermes, Inc.’s website (the “Website”). By using this website, you acknowledge your assent to these Terms and Conditions of Use (“Terms of Use”).

Alkermes may modify the Website and these Terms of Use at any time. Modifications will be posted on the Website, so please check back when you use the Website. By continuing use of the Website after such changes are posted, you will be presumed to have accepted any such changes applicable to you.

These Terms of Use are a binding agreement. If you do not agree to all of these Terms and Conditions of Use, do not use this Website.

Website Content

The Website is intended for general informational and educational purpose only. Alkermes is not engaged in rendering medical advice or similar professional services or advice via this Website, and the information provided is not intended to replace medical advice offered by a physician. If you desire or need such services or advice, you should consult a professional healthcare provider. 

Although the content of the Website is updated periodically, except as may be required by applicable law, Alkermes does not have a duty to update information contained in the Website and Alkermes will not be liable for any failure to update such information. Alkermes does not assume any responsibility or liability for the completeness, reliability or usefulness of the information disclosed or accessed through the Website. 


Alkermes respects the privacy of its Website users. Please refer to Alkermes’ Privacy Policy at for a detailed explanation of Website users’ rights and responsibilities with respect to information that is collected, used, or disclosed on or through the Website.

Pursuant to Section 230 of the U.S. Communications Decency Act, providers of interactive computer services shall not be treated as the publisher or speaker of any information provided by another information content provider. 

Scope of Use
Alkermes invites you to view the Website for your informational, non-commercial use. Except where download functionality is included in this Website and as otherwise provided in these Terms of Use, no part of any content or software on the Website may be copied, downloaded, or stored in a retrieval system for any other purpose, nor may it be redistributed for any purpose, without the express written permission of Alkermes. You understand that Alkermes may discontinue, change, or restrict use of the Website for any reason without notice. By using this Website, you represent that you are at least 18 years old. Additionally, by accessing the Website, you agree that you will not (i) circumvent, disable, breach, or compromise the Website or the systems used to provide the Website, including by using bots, crawlers, spiders, data miners, scraping, or other tools; (ii) interfere with, disrupt, damage, or compromise the Website or the systems used to provide the Website, including, without limitation, using viruses, denial-of-service attacks, packet injection, or by impossible unreasonable load on the Website; (iii) provide inaccurate or incomplete information to us; (iv) assist or permit any third party to violate these Terms of Use; and/or (iv) access or use the Website or its content in a manner that violates any applicable law.

No Warranties
Alkermes makes no representations or warranties that use of the Website will be uninterrupted or free from technical errors, computer viruses or other harmful content.   Furthermore, Alkermes is not responsible for the security or availability of the internet or any problems you may have related to the delay, failure, interruption, or corruption of any data or information transmitted in connection with your use of the Website.   All content on the Website is provided to you on an “as is” and “as available” basis without warranty of any kind either express or implied, including but not limited to any implied warranty of merchantability, fitness for a particular purpose, accuracy or non-infringement. Alkermes makes no warranty as to the accuracy, completeness, currency, or reliability of any content available or made available through the Website. These exclusions may not apply in jurisdictions that do not allow the exclusion of certain implied warranties.

Limitations of Liability
Your use of the website or any content on the website is at your own risk. Alkermes specifically disclaims any liability, whether based in contract, tort, strict liability or otherwise, for any direct, indirect, incidental, consequential, or special damages arising out of or in any way connected with access to or use of the Website, even if Alkermes has been advised of the possibility of such damages, including but not limited to reliance by any party on any content obtained through the use of the Website, or that arises in connection with mistakes or omissions in, or delays in transmission of, information to or from you, interruptions in telecommunications connections to the Website or viruses, whether caused in whole or in part by negligence, acts of God, “force majeure” events or circumstances, telecommunications failure, theft or destruction of, or unauthorized access to the Website, or related information or programs.

You agree to indemnify and hold harmless Alkermes from any claims, actions, demands, liabilities, or settlements, including without limitation, reasonable legal and accounting fees and other expenses, that arise out of any violation of these Terms of Use. You agree to cooperate as reasonably required in the defense of any such claim.      

IP Rights
All content of the Website is protected by U.S. and non-U.S. copyright laws. You may not copy, modify, upload, download, post, transmit, republish, or distribute any of the content, including without limitation the code, contained in the Website without our prior written permission except for your own personal, non-commercial purposes, and only if you acknowledge in writing the Website as the source of the material and attribute all rights of ownership to Alkermes, Inc., Alkermes Pharma Ireland Limited, or their affiliates. Except as provided in the preceding sentence, nothing contained in the Website shall be construed as granting a license or other rights under any patent, trademark, copyright, or other intellectual property of Alkermes, its affiliates or any third party. Unauthorized use of any Alkermes trademark, service mark or logo may be a violation of federal and/or state trademark laws. For updated information about Alkermes trademarks, service marks, and logos, see

Alkermes claims no ownership in, nor any affiliation with, any third-party trademarks appearing on this website. Such third-party trademarks are used only to identify the products and services of their respective owners, and no sponsorship or endorsement on the part of Alkermes should be inferred from the use of these marks.

The Website may contain links to websites, content, or platforms operated by other parties (“Linked Sites”). Any such Linked Sites are for your convenience only and not under the control of Alkermes, and Alkermes is not responsible for the Linked Sites or the content available on any Linked Site. Alkermes does not actually or impliedly endorse any of the Linked Sites. Alkermes disclaims all liability with regard to your access to the Linked Sites. Your use of the Linked Sites is at your own risk.

Unless otherwise set forth in a written agreement between you and Alkermes, you must adhere to Alkermes’ linking policy as follows: (i) any link to this Website must be a text only link clearly marked “” or “Alkermes website,” (ii) the appearance, position and other aspects of the link may not be such as to damage or dilute the goodwill associated with Alkermes’ names and trademarks, (iii) the link must “point” to and not to other pages within the Website, (iv) the appearance, position and other attributes of the link may not create the false appearance that your organization or entity is sponsored by, affiliated with, or associated with Alkermes, (v) when selected by a user, the link must display the Website on full-screen and not within a “frame” on the linking website, and (vi) Alkermes reserves the right to revoke its consent to the link at any time and in its sole discretion.

Limitations on Availability
Products referenced on the Website may not be available in all countries and/or may be available under a different trademark, in different strengths, or for different indications. Nothing contained on the Website should be construed as a solicitation or promotion for any product or service or for the use of any product in a particular way which is not authorized by the laws and regulations of the country where the reader is located.

Location and Governing Law

The Website is operated by Alkermes from its offices in Waltham, MA, USA. The law of the Commonwealth of Massachusetts shall govern these Terms of Use, without reference to its choice of law rules. Alkermes reserves the right to seek all remedies available at law and in equity for violations of these Terms of Use, including the right to block access from a particular Internet address to the Website. Alkermes makes no representation that the information in this Website is appropriate or available for use in other locations, and access to the Alkermes Website from territories where the content of the Website may be illegal is prohibited. Those who choose to access the Website from other locations do so on their own initiative and are responsible for compliance with applicable local laws.

Survival and Severability
All of these terms and conditions survive any termination of your use of the Website.  

If any provision of these Terms of Use is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of these Terms of Use shall remain in full force and effect. Any provision of these Terms of Use held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.

If you have questions about these Terms of Use, please send them via U.S. Mail to Alkermes, Inc. Legal Department, 900 Winter Street, Waltham, MA 02451 or via email to

This Website, including the presentations, webcasts and press releases made available through the Website, contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, but not limited to, statements  concerning: the company’s expectations with respect to its current and future financial and operating performance, business plans or prospects, including its development, manufacturing, regulatory and commercial activities; the potential therapeutic and commercial value of the company’s marketed products and development candidates; timelines, plans and expectations for development activities relating to the company’s products and development candidates; the company’s plans and expectations related to its commercial activities; and the company’s public policy, patient advocacy and engagement and corporate responsibility initiatives, policies and commitments and the intended impacts thereof, including the company’s environmental footprint, human capital management, corporate giving and grant programs and efforts to expand access to its medicines. These statements may include words like “believe,” “expect,” “may,” “will,” “should,” “seek,” or “anticipate,” and describe opinions or expectations about future events. The company cautions that forward-looking statements are inherently uncertain. The forward-looking statements are neither promises nor guarantees and they are necessarily subject to a high degree of uncertainty and risk. Actual performance and results may differ materially from those expressed or implied in the forward-looking statements due to various risks and uncertainties. These risks and uncertainties include, without limitation: the company may not be able to achieve its financial and operating business plans or targets in a timely manner or at all; the unfavorable outcome of arbitration or litigation, including so-called "Paragraph IV" litigation and other patent litigation which may lead to competition from generic drug manufacturers, or other disputes related to the company's products or product candidates or products using the company’s proprietary technologies; the results of the company’s development activities may not be timely, positive, or predictive of final results from such activities, results of future development activities or real-world results; the U.S. Food and Drug Administration (“FDA”) or regulatory authorities outside the U.S. may not agree with the company’s regulatory approval strategies or components of the company’s marketing applications; potential changes in cost, scope and duration of the company’s development programs; whether the company’s products or product candidates could be shown ineffective or unsafe; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company’s products; the company and its licensees may not be able to continue to successfully commercialize their products or support revenue growth from such products; there may be a reduction in payment rate or reimbursement for the company’s products or an increase in the company's financial obligations to government payers; the company’s products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading “Risk Factors” in the company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and subsequent filings made with the Securities and Exchange Commission (the “SEC”). These reports are available at or through the Investor section of the company’s website. Except as required by law, the company disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this Website.

LAST UPDATED: January 2024